Efficacy and safety of anticoagulation with heparin versus heparin plus epoprostenol in patients undergoing extracorporeal liver support with prometheus

Artificial Organs

Volumn 34, Issue 1, 2010, Pages 84-88

  Krisper, Peter ^a   Tiran, Beate ^a   Fliser, Danilo ^b   Haditsch, Bernd ^a   Stadlbauer, Vanessa ^b   Otto, Ronald ^a   Ernst, Thomas ^b   Kretschmer, Ulrich ^b   Stauber, Rudolf E ^a   Haller, Hermann ^b   Holzer, Herwig ^a   Manns, Michael P ^b   Rifai, Kinan ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Artificial liver; Epoprostenol; Heparin; Liver failure; Safety

Indexed keywords

ARTIFICIAL ORGANS; COAGULATION; PATIENT MONITORING; PATIENT TREATMENT; PROTEINS; SAFETY ENGINEERING;

ADVERSE EVENTS; ANTI-COAGULATION; ANTITHROMBIN; ARTIFICIAL LIVER; BLEEDINGS; EPOPROSTENOL; LIVER FAILURE; PLASMA ADSORPTION; PLASMA SEPARATION; PROMETHEUS;

POLYSACCHARIDES;

HEPARIN; PROSTACYCLIN; PROTEIN C; PROTEIN S; THROMBIN ANTITHROMBIN COMPLEX;

ADSORPTION; ADULT; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING TEST; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FILTER; HUMAN; LIVER SUPPORT; MALE; PRIORITY JOURNAL;

EID: 75649086504     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2009.00793.x     Document Type: Article

References (16)

1. Senzolo M, Burra P, Cholongitas E, Burroughs AK. New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol 2006 12 : 7725 7736.
2. Falkenhagen D, Strobl W, Vogt G, et al. Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances. Artif Organs 1999 23 : 81 6.
3. Rifai K, Ernst T, Kretschmer U, et al. Prometheus - a new extracorporeal system for the treatment of liver failure. J Hepatol 2003 39 : 984 990.
4. Herget-Rosenthal S, Lison C, Treichel U, et al. Citrate anticoagulated modified fractionated plasma separation and adsorption: first clinical efficacy and safety data in liver failure. J Am Soc Nephrol 2003 14 : 729A.
5. Krisper P, Haditsch B, Stauber R, et al. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol 2005 43 : 451 457.
6. Kozek-Langenecker SA, Kettner SC, Oismueller C, Gonano C, Speiser W, Zimpfer M. Anticoagulation with prostaglandin E1 and unfractionated heparin during continuous venovenous hemofiltration. Crit Care Med 1998 26 : 1208 1212.
7. Meijers BK, Verhamme P, Nevens F, et al. Major coagulation disturbances during fractionated plasma separation and adsorption. Am J Transplant 2007 7 : 2195 2199.
8. Krisper P, Stauber RE. Technology insight: artificial extracorporeal liver support - how does Prometheus compare with MARS? Nat Clin Pract Nephrol 2007 3 : 267 276.
9. Weber V, Linsberger I, Hauner M, Leistner A, Falkenhagen D. Neutral styrene divinylbenzene copolymers for adsorption of toxins in liver failure. Biomacromolecules 2008 9 : 1322 1328.
10. Bachli EB, Schuepbach RA, Maggiorini M, Stocker R, Mullhaupt B, Renner EL. Artificial liver support with the molecular adsorbent recirculating system: activation of coagulation and bleeding complications. Liver Int 2007 27 : 475 484.
11. Faybik P, Bacher A, Kozek-Langenecker SA, et al. Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study. Crit Care 2006 10 : R24.
12. Yang WS, Tan HK, Lui HF, Chow PK, Choong HL, Wong KS. Albumin dialysis in critically ill patients: use versus omission of intradialytic heparArtif Organs 2008 32 : 411 416.
13. Kramer L, Bauer E, Joukhadar C, et al. Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med 2003 31 : 2450 2455.
14. Weber V, Lind J, Linsberger I, Falkenhagen D. Activation of blood coagulation at adsorbent surfaces is efficiently reduced by pre-heparinization. Int J Artif Org 2006 29 : 521A.
15. Demetriou AA, Brown RS Jr., Busuttil RW, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004 239 : 660 667.
16. Zhang JJ, Meng XK, Dong C, et al. Development of a new animal model of liver cirrhosis in swine. Eur Surg Res 2009 42 : 35 9.